SavedAdd your journal

Journals / Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi / 2026 / Cilt: 1 Sayı: 1

Biotechnological Applications in the Field of Health: Red Biotechnology

Sağlık Alanında Biyoteknolojik Uygulamalar: Kırmızı Biyoteknoloji

Ülküye Dudu Gül
Pages
66–70
Publication Date
2016-07-01
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this study red biotechnology including biotechnological applications in the field of health reviewed in general.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Biotechnology is a scientific discipline which covers the production processes of economically valuable products.
📊
Key Findings & Data:Recently, especially together with the developments of genetic techniques like the transfer of genetic material one organism to another and avaliabilty of organisms for the production of commercially important new metabolites provides speed to biotechnological applications.
💡
Conclusion & Impact:In this study red biotechnology including biotechnological applications in the field of health reviewed in general.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Biyoteknoloji · Genetik · Sağlık

Abstract

Biotechnology is a scientific discipline which covers the production processes of economically valuable products. Recently, especially together with the developments of genetic techniques like the transfer of genetic material one organism to another and avaliabilty of organisms for the production of commercially important new metabolites provides speed to biotechnological applications. In this study red biotechnology including biotechnological applications in the field of health reviewed in general.

Özet

Biyoteknoloji canlı materyallerin kullanımıyla ekonomik değeri olan ürünlerin üretimini içeren süreçleri kapsayan bilim dalıdır. Son yıllarda özellikle genetik tekniklerin geliştirilmesiyle birlikte bir organizmadan diğerine genetik materyallerin transferi ve ticari öneme sahip yeni metabolitlerin üretiminin optimizasyonu için uygun organizmaların varlığı biyoteknolojik uygulamalara hız kazandırmıştır. Bu çalışmada biyoteknolojinin sağlık alanında gerçekleştirilen uygulamalarını kapsayan kırmızı biyoteknoloji üzerine genel bir derleme yapılmıştır.

🔖

Cite This Article

Gül, Ü. D. (2016). Biotechnological Applications in the Field of Health: Red Biotechnology. Bilecik Şeyh Edebali Üniversitesi Fen Bilimleri Dergisi, Cilt: 1 Sayı: 1, 66–70. https://ajindex.com/articles/1264773

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (25)

  1. Emtiazi, G., Principle of genetic engireeing and molecular biology., 2 nd ed.,Giti press, 2011.
  2. Gartland, K.M.A., Bruschi, F., Dundar, M., Gahan, P.B., Viola Magni, M.P., Akbarova, Y., “Progress towards the„Golden Age‟ of biotechnology”, Current Opinion in Biotechnology., vol. 24, pp. 6-13, 2013.
  3. Scott, K., Handbook of Industrial Membranes, 2 nd ed., 14, pp. 655- 680, 1998.
  4. Kolankaya, N.,“KüreselleĢme Sürecinde Biyoteknoloji ve Biyogüvenlik'', Biyoteknolojiye Bir Bakış: Dünya ve Türkiye Sempozyum Bildirileri Kitabı, T.C. Çevre Bakanlığı, T.C. Tarım ve KöyiĢleri Bakanlığı ve Biyoteknoloji Derneği Ortak Yayınları, Ankara, pp. 1- 6, 2000.
  5. Akkaya, A., Pazarlıoğlu, N., “21.Yüzyılın Anahtar Teknolojisi:Beyaz Biyoteknoloji”, Kırıkkale Üniversitesi Bilimde Gelişmeler Dergisi, pp. 22- 33, 2012.
  6. Zand, M., Narasu, M., “A review article Biotechnology Applications in Medicine”, Intl. Res. J. Appl. Basic. Sci., 4(9), pp. 2557-2563, 2013.
  7. King, G.D., Curtin, J.F., Candolfi, M., Kroeger, K., Lowenstein, P.R., Castro, M.G., “Gene therapy and targeted toxins for glioma”, Curr. Gene Ther., 5(6), pp. 535-57, 2005.
  8. The Genetics Home website. [online]. http://ghr.nlm.nih.gov/handbook/therapy/genetherapy, eriĢim tarihi: 2007.
  9. The Cancer Institute website. [online]. http://www.cancer.gov/cancertopics/factsheet/Therapy/Gene, eriĢim tarihi:10.09.2008.
  10. Watters, J.W., McLeod, H.L., “Cancer pharmacogenomics: Current and future applications”, Biochim. Biophys. Acta.,vol. 1603(2), pp. 99-111, 2003.
  11. Chasman, D. I., Posada, D., Subrahmanyan, L., Cook, N. R., Stanton, V. P., Ridker, P. M., “Pharmacogenomics study of statin therapy and cholesterol reduction”, JAMA, 291(23), pp. 2821-2827, 2004.
  12. Mancama, D., Kerwin, R.W., “Role of pharmacogenomics in individualising treatment with SSRIs”, CNS Drugs, vol.17(3), pp. 143-51, 2003.
  13. Anderson, J.L., Carlquist, J.F., Horne, B.D., Muhlestein, J.B., “Cardiovascular pharmacogenomics: current status, future prospects”, J. Cardiovasc. Pharmacol. Ther., vol. 8(1), pp. 71-83. 2003.
  14. Wolf, C.R., Smith, G., Smith, R.L., “Science, medicine and the future, Pharmacogenetics”, Br. Med. J., vol. 320, pp. 987-990, 2000.
  15. Tessari, A., Palmieri, D., Di Cosimo, S., “Overview of diagnostic/targeted treatment combinations in personalized medicine for breast cancer patients”, Pharmacogenomics and Personalized Medicine.,vol. 7, pp. 1–19, 2014.
  16. Vincent-Gattis, M., Webb, C., Foote, M.A., “Clinical research strategies in biotechnology”, Biotechnology Annual Review,vol. 5, pp. 259–267, 2000.
  17. Handman, E., ''Leishmaniasis: Current Status of Vaccine Development'', Clinical microbiology review, pp. 229–243, 2001.
  18. Ho, R.J.Y, Gibaldi, M., Biotechnology
  19. Recombivax., [online]. http://www.merck.com/product/usa/pi_circulars/r/recombivax_hb/recombivax_pi.pdf, eriĢim tarihi: 08.05. 2014.
  20. Comvax., [online]. http://www.merck.com/product/usa/pi_circulars/c/comvax/comvax_pi.pdf,eriĢim tarihi: 08.05. 2014.
  21. Engerix-, B., [online]. http://www.gsk.ca/english/docs-pdf/product-monographs/Engerix-B.pdf,eriĢim tarihi: 08.05. 2014.
  22. Gartland, K.M.A., Bruschi, F., Dundar, M., Gahan, P.B., Viola Magni, M.P., Akbarova, Y., “Progress towards the„Golden Age‟ of biotechnology”, Current Opinion in Biotechnology., vol. 24, pp. 6-13, 2013.
  23. Vincent-Gattis, M., Webb, C., Foote, M.A., “Clinical research strategies in biotechnology”, Biotechnology Annual Review,vol. 5, pp. 259–267, 2000.
  24. Comvax., [online]. http://www.merck.com/product/usa/pi_circulars/c/comvax/comvax_pi.pdf,eriĢim tarihi: 08.05. 2014.
  25. Engerix-, B., [online]. http://www.gsk.ca/english/docs-pdf/product-monographs/Engerix-B.pdf,eriĢim tarihi: 08.05. 2014.